![Christopher Beattie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Beattie
Public Communications Contact bij
BLACKROCK CAPITAL INVESTMENT CORPORATION
Profiel
Christopher Beattie is currently working as a Press Contact at BlackRock Capital Investment Corp.
Prior to this, he worked as a Director-Clinical & Regulatory Affairs at Onyvax Ltd. and as a Principal at Xenova Group Plc.
Actieve functies van Christopher Beattie
| Bedrijven | Functie | Begin |
|---|---|---|
| BLACKROCK CAPITAL INVESTMENT CORPORATION | Public Communications Contact | - |
Eerdere bekende functies van Christopher Beattie
| Bedrijven | Functie | Einde |
|---|---|---|
Xenova Group Plc
 Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | - |
Onyvax Ltd.
 Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Develops cancer remedy therapies | Algemeen Adviseur | 31-05-2012 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
BlackRock Capital Investment Corp
 BlackRock Capital Investment Corp Investment ManagersFinance Operates as a closed-end management investment company | Finance |
Onyvax Ltd.
Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Develops cancer remedy therapies | Commercial Services |
